Journal
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY
Volume 15, Issue 5, Pages 723-738Publisher
ELSEVIER SCI LTD
DOI: 10.1053/bega.2001.0231
Keywords
intestinal inflammation; intestinal permeability; inflammatory bowel disease; spondylarthropathy; non-steroidal anti-inflammatory drugs; enteropathy; drug toxicity
Categories
Ask authors/readers for more resources
Non-steroidal anti-inflammatory drugs cause small-bowel inflammation in about 60% of patients receiving these drugs long-term. The inflammation is associated with small intestinal bleeding, protein loss, ulcers and occasionally strictures. Treatment options for NSAID enteropathy include metronidazole, sulphasalazine and misoprostol, and some patients may require surgery. The diagnosis of NSAID enteropathy is not always straightforward. It is especially difficult to differentiate it from the ileitis associated with spondylarthropathy and, at times, that of Crohn's disease. An investigational algorithm is suggested for this purpose. In the last decade a number of small-bowel diseases have been identified, where none were thought to exist, because of the increasing use of enteroscopy and new sensitive tests for intestinal inflammation. Optimal treatments of these conditions are still to be studied.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available